To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SPCS1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
450 supporting clones for gene SPCS1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AI864119 pooled .a 1 to 237 241 to 1   tiling clone,   241/241
(100 %)
7 diff
(97.1 %id)
BG724036 testis .a 120 to 352 1 to 233       233/233
(100 %)
3 diff
(98.8 %id)
NM_014041.3   .a 124 to 1205 1 to 1082   RefSeq, AAA   1082/1082
(100 %)
0 diff
(100 %id)
DB459917 testis .a 125 to 582 1 to 458       458/458
(100 %)
0 diff
(100 %id)
BI464841 testis .a 127 to 352 1 to 226       226/226
(100 %)
3 diff
(98.7 %id)
DB444081 testis .a 131 to 580 1 to 451       451/451
(100 %)
4 diff
(99.2 %id)
DB474441 hippocampus .a 148 to 649 1 to 500       500/500
(100 %)
3 diff
(99.4 %id)
BU070128 insulinoma, Pancreas .a 194 to 604 8 to 418   tiling clone, fully sequenced,   411/418
(98 %)
6 diff
(98.6 %id)
AI924167 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 259 to 838 1 to 580     Submitted on the opposite strand 580/580
(100 %)
0 diff
(100 %id)
BF971148 adrenal cortex carcinoma, cell line, adrenal gland .a 312 to 1164 1 to 852       852/1057
(80 %)
42 diff
(96.1 %id)
CD709022 normal nasopharynx .a 370 to 746 23 to 399       377/399
(94 %)
7 diff
(98.3 %id)
W79708 heart .a 375 to 809 1 to 439       439/439
(100 %)
9 diff
(98.0 %id)
BG482684 lung .a 376 to 1143 1 to 779       779/826
(94 %)
37 diff
(95.6 %id)
BE764972 nervous_tumor .a 377 to 727 352 to 2       351/357
(98 %)
8 diff
(97.8 %id)
BF699289 brain, primitive neuroectoderm .a 378 to 1074 1 to 700       698/1112
(62 %)
42 diff
(96.3 %id)
BP306059   .a 379 to 957 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BU597687 mixed (pool of 40 RNAs) .a 380 to 1140 1 to 773       773/830
(93 %)
23 diff
(97.3 %id)
BU532390 mixed (pool of 40 RNAs) .a 380 to 1033 1 to 657       657/814
(80 %)
18 diff
(97.8 %id)
AW877810 ovary .a 382 to 762 1 to 376       380/382
(99 %)
19 diff
(95.1 %id)
BG944123 blood .a 382 to 1042 1 to 662       662/662
(100 %)
4 diff
(99.4 %id)
DB485906.
matches multiple genes
hypothalamus .a 382 to 823 1 to 440     also hits gene slofoybo 440/440
(100 %)
4 diff
(99.1 %id)
DB492067.
matches multiple genes
hypothalamus .a 382 to 826 1 to 444     also hits gene slofoybo 444/444
(100 %)
3 diff
(99.4 %id)
DB494692.
matches multiple genes
hypothalamus .a 382 to 895 1 to 513     also hits gene slofoybo 513/513
(100 %)
3 diff
(99.5 %id)
BF674585 Prostate .a 382 to 1045 1 to 662       662/886
(74 %)
22 diff
(97.6 %id)
BG616629 Liver .a 382 to 1186 1 to 804       804/893
(90 %)
22 diff
(97.6 %id)
CB857373 anterior tongue, pooled .a 382 to 823 1 to 442   fully sequenced,   442/442
(100 %)
2 diff
(99.6 %id)
CD683889 normal nasopharynx .a 383 to 1068 23 to 708       686/708
(96 %)
11 diff
(98.5 %id)
CD706172 normal nasopharynx .a 383 to 682 38 to 337       300/337
(89 %)
6 diff
(98.3 %id)
FN070724 breast carcinoma .a 383 to 472 4 to 95       92/95
(96 %)
6 diff
(93.7 %id)
DB467743 hippocampus .a 383 to 797 1 to 414       414/414
(100 %)
3 diff
(99.3 %id)
DB469019 hippocampus .a 383 to 803 1 to 421       421/421
(100 %)
2 diff
(99.6 %id)
CB987958 Human Placenta, placenta .a 383 to 808 29 to 454       426/458
(93 %)
7 diff
(98.5 %id)
CB988069 Human Placenta, placenta .a 383 to 1121 29 to 777       749/781
(95 %)
17 diff
(97.9 %id)
BM508970 insulinoma, Pancreas .a 384 to 985 1 to 602       602/602
(100 %)
6 diff
(99.1 %id)
BI604057 brain, hypothalamus .a 384 to 955 1 to 576       576/576
(100 %)
11 diff
(98.1 %id)
BI602297 brain, hypothalamus .a 384 to 1159 1 to 774       774/775
(99 %)
9 diff
(98.9 %id)
BI667261 brain, hypothalamus .a 384 to 1194 1 to 814       814/854
(95 %)
25 diff
(97.1 %id)
BM510367 insulinoma, Pancreas .a 384 to 839 1 to 456       456/456
(100 %)
7 diff
(98.5 %id)
BQ130776 insulinoma, Pancreas .a 384 to 839 1 to 456       456/456
(100 %)
6 diff
(98.7 %id)
BQ267242 insulinoma, Pancreas .a 384 to 850 1 to 467       467/467
(100 %)
6 diff
(98.8 %id)
DW444143 Liver .a 385 to 598 14 to 227       214/227
(94 %)
11 diff
(95.2 %id)
DW450794 Liver .a 385 to 566 14 to 195       182/196
(92 %)
5 diff
(97.5 %id)
EL948801 eyeball .a 386 to 902 1 to 519       519/519
(100 %)
6 diff
(98.9 %id)
FN130230 breast carcinoma .a 386 to 466 1 to 81       81/81
(100 %)
2 diff
(97.6 %id)
AI300946 carcinoid, lung .a 386 to 840 1 to 455     Submitted on the opposite strand 455/455
(100 %)
3 diff
(99.4 %id)
BM811016 amelanotic melanoma, cell line, skin .a 386 to 1002 1 to 619       619/1163
(53 %)
11 diff
(99.1 %id)
CN306846 embryonic stem cells, DMSO-treated H9 cellline .a 387 to 1039 1 to 654       654/654
(100 %)
4 diff
(99.4 %id)
BG622473 placenta .a 388 to 1113 1 to 724       724/724
(100 %)
13 diff
(98.3 %id)
AI541287 Tissue culture .a 389 to 719 30 to 361       332/738
(44 %)
13 diff
(98.3 %id)
AA995358 carcinoid, lung .a 389 to 887 1 to 499     Submitted on the opposite strand 499/499
(100 %)
5 diff
(99.0 %id)
TI_45209642   .a 389 to 955 90 to 660       571/660
(86 %)
12 diff
(98.2 %id)
BF670105 brain, primitive neuroectoderm .a 391 to 1100 1 to 709       709/875
(81 %)
61 diff
(93.1 %id)
BM472174 melanotic melanoma, skin .a 391 to 1016 78 to 707       630/1289
(48 %)
37 diff
(97.2 %id)
TI_45213871   .a 391 to 1159 89 to 855       767/856
(89 %)
10 diff
(98.9 %id)
TI_44343291   .a 391 to 1194 90 to 896       807/936
(86 %)
25 diff
(97.4 %id)
CD691967 normal nasopharynx .a 392 to 961 32 to 601       570/601
(94 %)
11 diff
(98.2 %id)
DB505893 hypothalamus .a 392 to 889 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
AF092138   .a 393 to 1192 1 to 798       798/798
(100 %)
3 diff
(99.7 %id)
N42404 melanocyte .a 393 to 869 1 to 477   fully sequenced,   477/477
(100 %)
7 diff
(98.6 %id)
BM836659 Ascites, stomach .a 393 to 942 1 to 550       550/550
(100 %)
0 diff
(100 %id)
BE048049 brain, tumor, 5 pooled (see description) .a 394 to 860 1 to 467       467/467
(100 %)
0 diff
(100 %id)
BG546792 lung .a 394 to 1192 1 to 803   AAA   803/803
(100 %)
23 diff
(97.2 %id)
AK027426   .a 395 to 1192 1 to 798   available from FLJ,   798/798
(100 %)
1 diff
(99.9 %id)
AX775783   .a 395 to 1192 1 to 798       798/798
(100 %)
2 diff
(99.8 %id)
CB120787 cervix, Uterine .a 395 to 950 1 to 556       556/556
(100 %)
3 diff
(99.5 %id)
BP235253 coronary artery .a 395 to 975 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
BP235926 coronary artery .a 395 to 976 1 to 582       582/582
(100 %)
8 diff
(98.7 %id)
BU537888 mixed (pool of 40 RNAs) .a 395 to 1131 1 to 738       738/738
(100 %)
8 diff
(99.0 %id)
DA128488 cerebellum .a 396 to 980 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
DA523456 brain .a 396 to 962 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA727708   .a 396 to 814 2 to 420   capped   419/423
(99 %)
3 diff
(99.3 %id)
BM353719 Pancreas, Purified pancreatic islet .a 397 to 912 23 to 538       516/538
(95 %)
6 diff
(98.9 %id)
FN068047 breast carcinoma .a 397 to 489 1 to 94       94/94
(100 %)
4 diff
(95.8 %id)
R23867 placenta .a 397 to 814 1 to 426       426/430
(99 %)
11 diff
(97.5 %id)
BU596134 mixed (pool of 40 RNAs) .a 397 to 1153 1 to 761       761/761
(100 %)
14 diff
(98.2 %id)
BP871195 embryonal kidney .a 398 to 730 1 to 333       333/333
(100 %)
2 diff
(99.4 %id)
CD708570 normal nasopharynx .a 398 to 739 22 to 363       342/363
(94 %)
7 diff
(98.1 %id)
BJ995711 hepatoblastoma .a 398 to 791 1 to 394   fully sequenced,   394/394
(100 %)
2 diff
(99.5 %id)
R33701 placenta .a 398 to 758 1 to 370       370/430
(86 %)
14 diff
(96.8 %id)
BG105075 adrenal cortex carcinoma, cell line, adrenal gland .a 398 to 1094 1 to 692       694/931
(74 %)
8 diff
(99.2 %id)
BG429309 Kidney .a 398 to 1117 1 to 715       715/723
(98 %)
10 diff
(98.7 %id)
CK002863 brain/CNS, Human Brain - Cerebellar Cortex .a 398 to 1057 1 to 653       653/668
(97 %)
13 diff
(98.1 %id)
BP299637   .a 398 to 947 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
BM851621 myeloma .a 398 to 833 1 to 437       437/446
(97 %)
27 diff
(94.0 %id)
BF679757 Prostate .a 399 to 1080 1 to 669       671/840
(79 %)
21 diff
(97.5 %id)
BP318836 pericardium .a 399 to 978 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CD246694 embryonic stem cells, WA01, passage 38 .a 401 to 1211 18 to 834       817/872
(93 %)
21 diff
(97.6 %id)
CD701874 normal nasopharynx .a 401 to 694 38 to 332       295/332
(88 %)
8 diff
(97.6 %id)
BY997425   .a 401 to 1044 1 to 644       644/644
(100 %)
0 diff
(100 %id)
DA732099   .a 401 to 844 2 to 452   capped   451/459
(98 %)
10 diff
(97.9 %id)
BM762101 myeloma .a 401 to 1067 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
BP356971 mammary gland .a 401 to 801 1 to 401       401/407
(98 %)
3 diff
(99.3 %id)
BU935094 mixed (pool of 40 RNAs) .a 403 to 1101 1 to 710       710/736
(96 %)
23 diff
(96.9 %id)
TI_154049285   .a 403 to 1192 890 to 102   AAA   789/976
(80 %)
8 diff
(99.2 %id)
AX775833   .a 405 to 1192 1 to 788       788/788
(100 %)
1 diff
(99.9 %id)
W38924 parathyroid gland, parathyroid tumor .a 405 to 790 1 to 393   fully sequenced,   393/393
(100 %)
5 diff
(98.8 %id)
L38852   .a 405 to 992 1 to 588       588/588
(100 %)
3 diff
(99.5 %id)
TI_149293381   .a 405 to 1192 853 to 68   AAA   786/953
(82 %)
5 diff
(99.5 %id)
BQ423345 large cell carcinoma, lung .a 407 to 1192 20 to 805       786/908
(86 %)
13 diff
(98.6 %id)
BP328197 rectum .a 408 to 989 1 to 581       581/582
(99 %)
5 diff
(99.2 %id)
BP328674 rectum .a 408 to 982 1 to 575       575/582
(98 %)
5 diff
(99.2 %id)
DB487074.
matches multiple genes
hypothalamus .a 410 to 852 1 to 443     also hits gene slofoybo 443/443
(100 %)
1 diff
(99.8 %id)
N42319 melanocyte .a 410 to 722 1 to 311       311/538
(57 %)
12 diff
(97.8 %id)
CD247824 embryonic stem cells, WA01, passage 38 .a 412 to 1192 23 to 803       781/892
(87 %)
10 diff
(98.9 %id)
CN306845 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 412 to 1185 1 to 774       774/774
(100 %)
1 diff
(99.9 %id)
EL949353 eyeball .a 412 to 983 1 to 572       572/572
(100 %)
4 diff
(99.4 %id)
BE973606 Prostate .a 412 to 935 1 to 522       522/522
(100 %)
4 diff
(99.3 %id)
BM511391 insulinoma, Pancreas .a 412 to 984 8 to 580       573/580
(98 %)
7 diff
(98.8 %id)
CK823841 insulinoma, Pancreas .a 412 to 971 8 to 567       560/567
(98 %)
6 diff
(99.0 %id)
AJ714217 bone marrow .a 413 to 785 1 to 374       374/374
(100 %)
2 diff
(99.5 %id)
TI_149294574   .a 415 to 1192 857 to 81   AAA   777/995
(78 %)
2 diff
(99.8 %id)
BU199042   .a 416 to 952 1 to 534       534/537
(99 %)
30 diff
(94.5 %id)
BF970013 adrenal cortex carcinoma, cell line, adrenal gland .a 416 to 1149 1 to 739       739/813
(90 %)
9 diff
(98.9 %id)
BG178384 adenocarcinoma, cell line, Prostate .a 416 to 1033 1 to 618       618/618
(100 %)
0 diff
(100 %id)
BU197288 eye, retinoblastoma .a 416 to 1197 1 to 784       784/784
(100 %)
7 diff
(99.2 %id)
TI_57162161   .a 416 to 1167 55 to 803       749/806
(92 %)
11 diff
(98.7 %id)
T35747 synovial membrane .a 416 to 718 1 to 303       303/303
(100 %)
1 diff
(99.7 %id)
N31382 melanocyte .a 417 to 845 1 to 433   fully sequenced,   433/433
(100 %)
4 diff
(99.1 %id)
N33735 melanocyte .a 417 to 801 1 to 392   fully sequenced,   392/392
(100 %)
3 diff
(99.3 %id)
BU182621 melanotic melanoma, skin .a 417 to 1046 10 to 641       632/923
(68 %)
11 diff
(98.9 %id)
CN306844 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 418 to 981 1 to 564       564/564
(100 %)
4 diff
(99.3 %id)
CD696940 normal nasopharynx .a 419 to 1053 30 to 663       634/663
(95 %)
9 diff
(98.7 %id)
N23506 melanocyte .a 419 to 872 1 to 459   fully sequenced,   459/459
(100 %)
13 diff
(97.2 %id)
W95089 liver and spleen .a 419 to 836 1 to 416   fully sequenced,   416/416
(100 %)
5 diff
(98.8 %id)
BI830738 brain, medulla .a 419 to 1189 1 to 767       767/767
(100 %)
6 diff
(99.3 %id)
BU600707 mixed (pool of 40 RNAs) .a 419 to 1189 1 to 782       782/794
(98 %)
25 diff
(96.9 %id)
CA453961   .a 419 to 1194 1 to 778       778/783
(99 %)
4 diff
(99.5 %id)
TI_57172777   .a 419 to 1189 64 to 830       767/830
(92 %)
11 diff
(98.7 %id)
BI335113 cervical carcinoma cell line, cervix .a 420 to 989 163 to 731       569/731
(77 %)
17 diff
(97.7 %id)
BQ220577 melanotic melanoma, skin .a 420 to 1054 1 to 641       641/968
(66 %)
15 diff
(98.5 %id)
AV742727 cord Blood .a 421 to 960 43 to 564       524/609
(86 %)
20 diff
(96.8 %id)
BI832450 pooled pancreas and spleen .a 421 to 1167 1 to 744       744/747
(99 %)
5 diff
(99.4 %id)
BM875694 insulinoma, Pancreas .a 421 to 743 8 to 330   fully sequenced,   323/330
(97 %)
6 diff
(98.2 %id)
TI_57219160   .a 421 to 1174 24 to 782       759/782
(97 %)
17 diff
(97.9 %id)
BU532829 mixed (pool of 40 RNAs) .a 422 to 1112 1 to 699       699/799
(87 %)
28 diff
(96.5 %id)
BP421787 small intestine .a 423 to 924 1 to 502     Submitted on the opposite strand 502/502
(100 %)
1 diff
(99.9 %id)
R28433 placenta .a 423 to 711 1 to 293       293/293
(100 %)
9 diff
(97.0 %id)
BU170104 epithelioid carcinoma, Pancreas .a 423 to 1192 1 to 770       770/894
(86 %)
6 diff
(99.4 %id)
BI752480 brain .a 426 to 1174 1 to 754       754/754
(100 %)
13 diff
(98.3 %id)
DR005262 Prostate .a 426 to 1050 8 to 633       626/633
(98 %)
16 diff
(97.5 %id)
R22630 placenta .a 427 to 743 1 to 325       325/326
(99 %)
13 diff
(96.1 %id)
BU658709 blood .a 428 to 832 1 to 405       405/405
(100 %)
16 diff
(96.1 %id)
R74310 placenta .a 428 to 902 1 to 488   fully sequenced,   488/488
(100 %)
19 diff
(96.2 %id)
BE896959 melanotic melanoma, skin .a 428 to 1194 1 to 767       767/767
(100 %)
21 diff
(97.3 %id)
N33907 melanocyte .a 429 to 712 1 to 284       284/292
(97 %)
3 diff
(99.0 %id)
BI826431 brain, medulla .a 430 to 1298 1 to 870   tiling clone,   870/870
(100 %)
17 diff
(98.1 %id)
BI603600 brain, hypothalamus .a 430 to 1192 1 to 760   AAA   760/760
(100 %)
11 diff
(98.6 %id)
TI_57173471   .a 430 to 1298 30 to 899       870/899
(96 %)
22 diff
(97.6 %id)
AA157599   .a 431 to 802 1 to 375   fully sequenced,   375/375
(100 %)
5 diff
(98.7 %id)
BU161514 melanotic melanoma, skin .a 431 to 1192 1 to 764   AAA   764/764
(100 %)
3 diff
(99.7 %id)
CA776601 Pancreas, Purified pancreatic islet .a 431 to 743 1 to 313   fully sequenced,   313/313
(100 %)
0 diff
(100 %id)
TI_45216338   .a 431 to 1192 126 to 884   AAA   759/884
(85 %)
10 diff
(98.9 %id)
BE782150 eye, retinoblastoma .a 433 to 1137 1 to 698       698/915
(76 %)
13 diff
(98.6 %id)
BM707510 eye, eye anterior segment .a 433 to 852 1 to 420   fully sequenced,   420/420
(100 %)
6 diff
(98.6 %id)
N42420 melanocyte .a 434 to 831 1 to 398   fully sequenced,   398/398
(100 %)
4 diff
(99.0 %id)
BE785316 large cell carcinoma, lung .a 434 to 1090 1 to 663       663/1011
(65 %)
32 diff
(96.9 %id)
DB506192 hypothalamus .a 435 to 913 1 to 479       479/479
(100 %)
3 diff
(99.4 %id)
CB993034 placenta, pre-eclamptic placenta .a 436 to 1146 28 to 743       716/834
(85 %)
19 diff
(97.8 %id)
CB998222 placenta, pre-eclamptic placenta .a 436 to 982 28 to 582       555/859
(64 %)
28 diff
(96.8 %id)
CB961902 placenta, pre-eclamptic placenta .a 436 to 1205 28 to 799       772/800
(96 %)
19 diff
(97.7 %id)
BM147910 leukopheresis .a 437 to 884 1 to 449       449/452
(99 %)
24 diff
(94.7 %id)
BE547758 cervical carcinoma cell line, cervix .a 441 to 1073 1 to 651       646/978
(66 %)
48 diff
(95.1 %id)
BE890490 melanotic melanoma, skin .a 442 to 1101 1 to 656       656/659
(99 %)
16 diff
(97.6 %id)
BM449597 melanotic melanoma, skin .a 443 to 1192 16 to 765   AAA   750/765
(98 %)
6 diff
(99.3 %id)
BQ213613 large cell carcinoma, lung .a 444 to 1192 9 to 758   AAA   750/758
(98 %)
7 diff
(99.1 %id)
AI090035 uterus .a 446 to 649 204 to 1       204/204
(100 %)
2 diff
(99.1 %id)
BU172271 melanotic melanoma, skin .a 450 to 1192 1 to 743       743/744
(99 %)
2 diff
(99.8 %id)
TI_149288176   .a 451 to 1192 827 to 91   AAA   737/976
(75 %)
12 diff
(98.8 %id)
BI094516 cervix .a 452 to 1132 17 to 706       690/723
(95 %)
39 diff
(94.7 %id)
BM474952 duodenal adenocarcinoma, cell line, small intestine .a 452 to 1192 1 to 741       741/741
(100 %)
0 diff
(100 %id)
BM542072 melanotic melanoma, skin .a 454 to 1192 1 to 741   AAA   741/741
(100 %)
5 diff
(99.4 %id)
CA406762 adipose .a 455 to 888 1 to 433       433/433
(100 %)
2 diff
(99.6 %id)
BE074234 breast .a 457 to 1028 572 to 1     Submitted on the opposite strand 572/572
(100 %)
2 diff
(99.7 %id)
T19230   .a 457 to 788 1 to 331       331/334
(99 %)
2 diff
(99.5 %id)
W57541 heart .a 457 to 824 1 to 372       372/392
(94 %)
11 diff
(97.2 %id)
N29163 melanocyte .a 461 to 865 1 to 408       408/409
(99 %)
5 diff
(98.8 %id)
AA293374 ovarian tumor, ovary .a 461 to 875 1 to 414   fully sequenced,   414/414
(100 %)
2 diff
(99.6 %id)
T31783 colon, embryo .a 461 to 803 1 to 343       343/343
(100 %)
0 diff
(100 %id)
BP203071 coronary artery .a 467 to 1048 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AA063083 pineal gland .a 469 to 813 1 to 348     Submitted on the opposite strand 348/348
(100 %)
7 diff
(98.0 %id)
H40733 brain .a 471 to 869 1 to 407       407/470
(86 %)
12 diff
(97.5 %id)
H45202 brain .a 472 to 840 1 to 372       372/514
(72 %)
12 diff
(97.7 %id)
BE910195 epithelioid carcinoma, Pancreas .a 473 to 1197 1 to 717       717/717
(100 %)
20 diff
(97.3 %id)
BE783656 eye, retinoblastoma .a 476 to 1182 1 to 700       700/702
(99 %)
9 diff
(98.8 %id)
AW297741   .a 480 to 651 190 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 198/190
(104 %)
50 diff
(73.7 %id)
AV747543 Pituitary .a 485 to 1024 1 to 539       539/549
(98 %)
10 diff
(98.2 %id)
BQ574689 Chondrosarcoma Grade II, Left Pelvis .a 485 to 1192 726 to 19   AAA   708/708
(100 %)
1 diff
(99.9 %id)
AV754940 pituitary tumor .a 488 to 1081 1 to 587       587/589
(99 %)
17 diff
(97.2 %id)
BE906341 epithelioid carcinoma, Pancreas .a 490 to 1186 1 to 699       699/699
(100 %)
7 diff
(99.0 %id)
TI_149292749   .a 491 to 1192 791 to 90   AAA   702/702
(100 %)
1 diff
(99.9 %id)
BQ306950 breast .a 494 to 1045 54 to 605       552/606
(91 %)
28 diff
(95.4 %id)
BM975120 lung .a 494 to 1192 717 to 19   AAA   699/699
(100 %)
0 diff
(100 %id)
TI_149289861   .a 495 to 1192 784 to 89   AAA   696/696
(100 %)
1 diff
(99.9 %id)
BM272313 Pancreas, Purified pancreatic islet .a 499 to 1047 1 to 549       549/549
(100 %)
0 diff
(100 %id)
CA777154 Pancreas, Purified pancreatic islet .a 504 to 1033 1 to 530       530/530
(100 %)
0 diff
(100 %id)
CB069486 Pancreas, Purified pancreatic islet .a 504 to 835 1 to 332       332/332
(100 %)
1 diff
(99.7 %id)
CA941524 Pancreas, Purified pancreatic islet .a 504 to 743 1 to 240   fully sequenced,   240/240
(100 %)
0 diff
(100 %id)
CA427263 Bone, Subchondral Bone .a 507 to 1128 640 to 19   AAA   622/637
(97 %)
0 diff
(100 %id)
BF743351 breast .a 516 to 944 15 to 443       429/453
(94 %)
8 diff
(98.3 %id)
AA507156 Prostate .a 516 to 927 1 to 412       412/412
(100 %)
2 diff
(99.6 %id)
BM973020 lung .a 516 to 1192 693 to 19   AAA   675/675
(100 %)
1 diff
(99.9 %id)
BU681260 lung .a 518 to 1192 693 to 19   AAA   675/675
(100 %)
2 diff
(99.8 %id)
CA413443 Chondrosarcoma Grade II, Left Pelvis .a 519 to 1192 692 to 19   AAA   674/674
(100 %)
1 diff
(99.9 %id)
BQ574063 Chondrosarcoma Grade II, Left Pelvis .a 519 to 1192 692 to 19   AAA   674/674
(100 %)
0 diff
(100 %id)
BQ182310 Knee, Osteoarthritic Cartilage .a 525 to 1192 686 to 19   AAA   668/668
(100 %)
0 diff
(100 %id)
AW006794 colon .a 527 to 1192 681 to 17   AAA   665/665
(100 %)
9 diff
(98.7 %id)
AI983025 brain, three pooled meningiomas .a 527 to 1192 680 to 15   AAA   666/666
(100 %)
10 diff
(98.5 %id)
AW510702 pooled .a 527 to 1194 672 to 5       668/672
(99 %)
0 diff
(100 %id)
BE880216 large cell carcinoma, undifferentiated, lung .a 529 to 1194 1 to 657       657/805
(81 %)
13 diff
(98.4 %id)
AW583802 Islets of Langerhans, Pancreas .a 529 to 795 1 to 268       268/268
(100 %)
14 diff
(94.8 %id)
AW188107 pooled .a 530 to 1194 672 to 8       665/672
(98 %)
3 diff
(99.6 %id)
CA309210 Alveolar Macrophage, lung .a 534 to 1205 690 to 19   AAA   672/672
(100 %)
2 diff
(99.8 %id)
AI015619   .a 542 to 1192 662 to 12   AAA   651/651
(100 %)
2 diff
(99.7 %id)
AI301966 2 pooled tumors (clear cell type), Kidney .a 542 to 1194 653 to 2       652/653
(99 %)
2 diff
(99.7 %id)
AI583243 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 542 to 1123 582 to 1       582/582
(100 %)
0 diff
(100 %id)
AA912616 pooled .a 544 to 703 1 to 160     Submitted on the opposite strand 160/160
(100 %)
2 diff
(98.8 %id)
BM974813 lung .a 554 to 1192 657 to 19   AAA   639/639
(100 %)
0 diff
(100 %id)
BM985091 lung .a 554 to 1192 657 to 19   AAA   639/639
(100 %)
0 diff
(100 %id)
BE714145 head_neck .a 560 to 801 266 to 25       242/266
(90 %)
1 diff
(99.7 %id)
BM314483 Pancreas, Purified pancreatic islet .a 564 to 917 1 to 354       354/354
(100 %)
0 diff
(100 %id)
AI360252 anaplastic oligodendroglioma, brain .a 565 to 1194 637 to 8       630/642
(98 %)
10 diff
(98.5 %id)
AW051432 brain, glioblastoma (pooled) .a 565 to 1194 629 to 1       629/638
(98 %)
2 diff
(99.7 %id)
AW168796 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 565 to 1192 628 to 1       628/633
(99 %)
1 diff
(99.9 %id)
BE858813 brain, glioblastoma (pooled) .a 565 to 1192 639 to 12   AAA   628/630
(99 %)
3 diff
(99.6 %id)
BG054826 brain, glioblastoma (pooled) .a 565 to 1192 627 to 1       627/629
(99 %)
5 diff
(99.3 %id)
AW630926 2 pooled high-grade transitional celltumors, genitourinary tract .a 568 to 884 1 to 317   fully sequenced,   317/317
(100 %)
0 diff
(100 %id)
AI125994 uterus .a 573 to 1192 631 to 11   AAA   621/621
(100 %)
5 diff
(99.2 %id)
BU069890 insulinoma, Pancreas .a 574 to 1197 646 to 23   tiling clone, fully sequenced, AAA   624/624
(100 %)
0 diff
(100 %id)
T31262 brain .a 579 to 893 1 to 322       322/329
(97 %)
13 diff
(96.1 %id)
BM510562 insulinoma, Pancreas .a 580 to 1192 629 to 17   AAA   613/613
(100 %)
0 diff
(100 %id)
BQ680964 melanotic melanoma, cell line, skin .a 582 to 1192 1 to 611   AAA   611/611
(100 %)
3 diff
(99.6 %id)
AW071976 anaplastic oligodendroglioma, brain .a 584 to 1194 615 to 4       612/615
(99 %)
6 diff
(99.1 %id)
BQ682789 melanotic melanoma, cell line, skin .a 584 to 1192 1 to 609   AAA   609/609
(100 %)
0 diff
(100 %id)
BE881479 large cell carcinoma, undifferentiated, lung .a 590 to 1188 1 to 596       596/596
(100 %)
4 diff
(99.4 %id)
BE879146 large cell carcinoma, undifferentiated, lung .a 591 to 1193 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
BP417335 small intestine .a 596 to 1122 1 to 526     Submitted on the opposite strand 526/526
(100 %)
1 diff
(99.9 %id)
BE693583 breast .a 599 to 933 332 to 1       332/332
(100 %)
4 diff
(98.8 %id)
AW149790 brain, medulloblastoma .a 599 to 1192 610 to 16   AAA   595/595
(100 %)
7 diff
(98.9 %id)
BU940182 mixed (pool of 40 RNAs) .a 600 to 1194 1 to 595       595/803
(74 %)
7 diff
(99.2 %id)
BQ354770 head_neck .a 601 to 1053 452 to 3       450/469
(95 %)
14 diff
(97.1 %id)
BU532382 mixed (pool of 40 RNAs) .a 603 to 1195 1 to 593       593/603
(98 %)
5 diff
(99.2 %id)
BM314175 Pancreas, Purified pancreatic islet .a 604 to 1192 604 to 16   AAA   589/591
(99 %)
5 diff
(99.2 %id)
ES311881 frontal balding hair, skin .a 605 to 765 1 to 162       162/162
(100 %)
5 diff
(97.0 %id)
BM272115 Pancreas, Purified pancreatic islet .a 614 to 1194 588 to 8       581/588
(98 %)
0 diff
(100 %id)
BG538553 lung .a 621 to 1192 1 to 572   AAA   572/572
(100 %)
2 diff
(99.7 %id)
AI912804 carcinoid, lung .a 624 to 1137 1 to 514     Submitted on the opposite strand 514/519
(99 %)
1 diff
(99.9 %id)
CA309990 Alveolar Macrophage, lung .a 654 to 1262 625 to 17   tiling clone, AAA   609/609
(100 %)
0 diff
(100 %id)
BM875443 insulinoma, Pancreas .a 682 to 1192 527 to 17   fully sequenced, AAA   511/511
(100 %)
0 diff
(100 %id)
CA776364 Pancreas, Purified pancreatic islet .a 682 to 1194 517 to 5   fully sequenced,   513/517
(99 %)
0 diff
(100 %id)
CA941233 Pancreas, Purified pancreatic islet .a 682 to 1194 519 to 7   fully sequenced,   513/519
(98 %)
0 diff
(100 %id)
N94922 parathyroid gland, parathyroid tumor .a 760 to 1124 366 to 1   fully sequenced,   366/366
(100 %)
1 diff
(99.8 %id)
BJ995712 hepatoblastoma .a 761 to 1156 396 to 1   fully sequenced,   396/396
(100 %)
1 diff
(99.8 %id)
N24587 melanocyte .a 771 to 1192 423 to 1   fully sequenced,   423/423
(100 %)
1 diff
(99.8 %id)
AA147675   .a 772 to 1193 423 to 1   fully sequenced,   423/423
(100 %)
1 diff
(99.8 %id)
CB857372 anterior tongue, pooled .a 793 to 1192 443 to 44   fully sequenced, AAA   400/400
(100 %)
0 diff
(100 %id)
N33447 melanocyte .a 801 to 1192 392 to 1   fully sequenced,   392/392
(100 %)
0 diff
(100 %id)
W95090 liver and spleen .a 806 to 1192 390 to 1   fully sequenced,   390/390
(100 %)
0 diff
(100 %id)
N24088 melanocyte .a 815 to 1192 379 to 1   fully sequenced,   379/379
(100 %)
0 diff
(100 %id)
BM673357 eye, eye anterior segment .a 822 to 1192 389 to 19   fully sequenced, AAA   371/371
(100 %)
1 diff
(99.8 %id)
W81380 heart .a 823 to 1192 373 to 1       373/375
(99 %)
7 diff
(98.2 %id)
N33428 melanocyte .a 839 to 1192 362 to 1   fully sequenced,   362/362
(100 %)
10 diff
(97.3 %id)
H45185 brain .a 845 to 1193 364 to 1       364/364
(100 %)
14 diff
(96.2 %id)
AA398521 ovarian tumor, ovary .a 845 to 1199 355 to 1   fully sequenced,   355/355
(100 %)
5 diff
(98.6 %id)
AW627640 2 pooled high-grade transitional celltumors, genitourinary tract .a 854 to 1193 340 to 1   fully sequenced,   340/340
(100 %)
0 diff
(100 %id)
AA946607 2 pooled tumors (clear cell type), Kidney .a 857 to 1208 352 to 1       352/352
(100 %)
0 diff
(100 %id)
AA938014 2 pooled tumors (clear cell type), Kidney .a 859 to 1205 347 to 1       347/347
(100 %)
0 diff
(100 %id)
H97133 melanocyte .a 870 to 1177 308 to 1   fully sequenced,   308/308
(100 %)
0 diff
(100 %id)
R74212 placenta .a 872 to 1174 304 to 1   fully sequenced,   304/304
(100 %)
1 diff
(99.7 %id)
R22631 placenta .a 898 to 1191 300 to 1       300/328
(91 %)
10 diff
(97.0 %id)
R25406 placenta .a 970 to 1192 239 to 15   AAA   225/225
(100 %)
2 diff
(99.2 %id)
BG702506 brain, hippocampus .b -8 to 822 1 to 827 P18A L109F W110V V111G L112I ... tiling clone,   827/827
(100 %)
23 diff
(97.3 %id)
DB477079 hippocampus .b 1 to 491 2 to 492 P18A tiling clone,   492/492
(100 %)
2 diff
(99.6 %id)
BF727414 eye, lens .c 1 to 634 8 to 641 P18A tiling clone,   641/641
(100 %)
2 diff
(99.7 %id)
BF115412 fibrotheoma, ovary .c 180 to 711 619 to 1       541/619
(87 %)
28 diff
(95.5 %id)
AA918990 2 pooled tumors (clear cell type), Kidney .c 211 to 712 512 to 5   tiling clone,   504/512
(98 %)
0 diff
(100 %id)
BX282731 lymph, lymphoma, cell line .d 1 to 487 1 to 487 P18A tiling clone,   487/487
(100 %)
1 diff
(99.8 %id)
BM458638 lymph, lymphoma, cell line .d 2 to 793 1 to 796       796/862
(92 %)
6 diff
(99.4 %id)
TI_154126361   .d 3 to 791 876 to 93   tiling clone, AAA   784/929
(84 %)
11 diff
(98.9 %id)
BQ429041 testis .d 25 to 652 1 to 633   tiling clone,   633/826
(76 %)
14 diff
(98.4 %id)
CA416517 Chondrosarcoma Cell line .d 113 to 791 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
TI_57164935   .e 3 to 674 66 to 732   tiling clone,   671/867
(77 %)
25 diff
(97.2 %id)
BI836224 pooled pancreas and spleen .e 6 to 674 1 to 664       664/799
(83 %)
21 diff
(97.4 %id)
BG696107 skin .e 16 to 971 1 to 952 G4A L39K Q59S E60R S61I ...     952/975
(97 %)
48 diff
(95.1 %id)
BP208145 cerebellum .e 283 to 860 1 to 578 K67E     578/578
(100 %)
1 diff
(99.9 %id)
BU853887 testis .e 316 to 1036 1 to 726 exact tiling clone,   726/775
(93 %)
16 diff
(98.0 %id)
N71994 melanocyte .e 732 to 1143 413 to 1   tiling clone,   413/415
(99 %)
1 diff
(99.8 %id)
BU954136 mixed (pool of 40 RNAs) .f 1 to 807 1 to 817 exact tiling clone,   817/908
(89 %)
20 diff
(97.8 %id)
EC528343 Prostate .f 214 to 322 1 to 109       109/109
(100 %)
0 diff
(100 %id)
Z42779 brain, total brain .f 216 to 423 1 to 208       208/208
(100 %)
2 diff
(99.1 %id)
FN050537 breast carcinoma .f 228 to 317 90 to 1     Submitted on the opposite strand 90/90
(100 %)
1 diff
(98.9 %id)
BU078724 Pancreas, Purified pancreatic islet .f 257 to 834 593 to 15   AAA   579/624
(92 %)
14 diff
(97.8 %id)
FN128722 breast carcinoma .f 263 to 354 1 to 91       91/101
(90 %)
4 diff
(96.1 %id)
CB117496 Liver .f 266 to 580 1 to 315       315/315
(100 %)
2 diff
(99.4 %id)
BI468417 insulinoma, Pancreas .f 267 to 834 585 to 18   AAA   568/622
(91 %)
18 diff
(97.2 %id)
CA943933 Pancreas, Purified pancreatic islet .f 271 to 836 572 to 6       567/598
(94 %)
12 diff
(98.0 %id)
BE122666 skin .f 289 to 759 1 to 471       471/471
(100 %)
2 diff
(99.6 %id)
EC534028 Prostate .f 296 to 396 99 to 1       99/99
(100 %)
2 diff
(98.0 %id)
BF196614 brain, glioblastoma (pooled) .f 303 to 831 531 to 4       528/531
(99 %)
13 diff
(97.6 %id)
AI805679 serous papillary carcinoma, high grade, 2pooled tumors, uterus .f 308 to 836 529 to 2       528/529
(99 %)
0 diff
(100 %id)
AA846833 parathyroid gland, parathyroid tumor .f 309 to 836 532 to 5   tiling clone,   528/532
(99 %)
0 diff
(100 %id)
BF184398 bone marrow, from chronic myelogenous leukemia .f 313 to 814 1 to 501       501/810
(61 %)
7 diff
(99.2 %id)
BM708448 eye, RPE and Choroid .f 329 to 834 1 to 506   fully sequenced, AAA   506/506
(100 %)
0 diff
(100 %id)
EC504357 Prostate .f 330 to 430 1 to 99       99/99
(100 %)
6 diff
(94.0 %id)
BM703965 eye, Retina Foveal and Macular .f 332 to 831 1 to 500       500/500
(100 %)
0 diff
(100 %id)
EC446042 Prostate .f 333 to 430 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
EC475395 Prostate .f 333 to 430 1 to 98       98/98
(100 %)
0 diff
(100 %id)
EC547916 Prostate .f 333 to 430 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
AA702505 liver and spleen .f 335 to 834 500 to 1       500/500
(100 %)
0 diff
(100 %id)
BP390949 pancreatic islet .f 337 to 834 1 to 499     Submitted on the opposite strand 499/499
(100 %)
1 diff
(99.8 %id)
BU730766 eye, RPE and Choroid .f 337 to 834 516 to 19   fully sequenced, AAA   498/498
(100 %)
0 diff
(100 %id)
AI955820 adenocarcinoma, Pancreas .f 339 to 834 506 to 11   AAA   496/496
(100 %)
0 diff
(100 %id)
EC512612 Prostate .f 342 to 425 3 to 87       85/87
(97 %)
6 diff
(93.2 %id)
AI128802 heart .f 345 to 836 492 to 1       492/492
(100 %)
3 diff
(99.4 %id)
DB577188 hypothalamus .f 346 to 834 1 to 489     Submitted on the opposite strand 489/489
(100 %)
0 diff
(100 %id)
R67980 placenta .f 349 to 684 1 to 345   fully sequenced,   345/345
(100 %)
9 diff
(97.4 %id)
FN056993 breast carcinoma .f 351 to 454 1 to 103       103/108
(95 %)
3 diff
(97.3 %id)
EC548643 Prostate .f 354 to 425 17 to 88       72/88
(81 %)
6 diff
(93.2 %id)
AA769460 germinal center B cell .f 354 to 836 516 to 33       484/524
(92 %)
0 diff
(100 %id)
AI581725 aorta .f 354 to 834 481 to 1       481/488
(98 %)
3 diff
(99.4 %id)
EC506808 Prostate .f 355 to 435 12 to 94       83/96
(86 %)
2 diff
(98.0 %id)
BG183979   .f 358 to 834 12 to 490   AAA   479/490
(97 %)
6 diff
(98.8 %id)
BG188177   .f 358 to 834 9 to 484   AAA   476/484
(98 %)
9 diff
(98.2 %id)
BG210450   .f 358 to 834 9 to 487   AAA   479/487
(98 %)
7 diff
(98.6 %id)
DB543260 hippocampus .f 358 to 834 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
EC528800 Prostate .f 361 to 449 1 to 90       90/91
(98 %)
5 diff
(94.6 %id)
EC542956 Prostate .f 361 to 449 1 to 91       91/92
(98 %)
6 diff
(93.5 %id)
DB384283   .f 361 to 847 488 to 1   tiling clone,   488/519
(94 %)
11 diff
(97.9 %id)
AA527383 colon .f 364 to 834 471 to 1       471/471
(100 %)
0 diff
(100 %id)
EC475686 Prostate .f 367 to 449 9 to 92       84/93
(90 %)
5 diff
(94.7 %id)
AI025955 parathyroid gland, parathyroid tumor .f 367 to 836 474 to 6       469/474
(98 %)
0 diff
(100 %id)
AI418108 brain, glioblastoma (pooled) .f 369 to 836 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AA702099 pineal gland .f 373 to 836 471 to 8       464/471
(98 %)
0 diff
(100 %id)
BG251694 adenocarcinoma, cell line, Liver .f 374 to 840 1 to 464   AAA   464/464
(100 %)
3 diff
(99.4 %id)
AA886635 metastatic prostate bone lesion .f 375 to 807 1 to 433       433/433
(100 %)
6 diff
(98.7 %id)
AI308924 adenocarcinoma, colon .f 375 to 834 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AI720299 colon .f 376 to 785 411 to 2       410/411
(99 %)
0 diff
(100 %id)
BG288732 bladder, transitional cell papilloma, cell line .f 376 to 834 1 to 457   AAA   457/457
(100 %)
2 diff
(99.6 %id)
BG109223 Bone, osteosarcoma, cell line .f 378 to 834 15 to 471   AAA   457/471
(97 %)
6 diff
(98.8 %id)
DB536487 hippocampus .f 380 to 834 1 to 456     Submitted on the opposite strand 456/456
(100 %)
1 diff
(99.8 %id)
H42168 brain .f 380 to 698 1 to 329   fully sequenced,   329/329
(100 %)
4 diff
(98.8 %id)
H50365 brain .f 380 to 610 1 to 236   fully sequenced,   236/236
(100 %)
0 diff
(100 %id)
F30122 pectoral muscle (after mastectomy) .f 381 to 612 1 to 232       232/232
(100 %)
0 diff
(100 %id)
AI718979 aorta .f 383 to 834 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
AI857970 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f 384 to 836 456 to 4       453/456
(99 %)
0 diff
(100 %id)
BP386719 pancreatic islet .f 385 to 836 1 to 454     Submitted on the opposite strand 454/459
(98 %)
5 diff
(99.0 %id)
H13228 placenta .f 386 to 670 293 to 1       293/298
(98 %)
13 diff
(95.7 %id)
DB545748 hippocampus .f 387 to 834 1 to 448     Submitted on the opposite strand 448/448
(100 %)
2 diff
(99.6 %id)
AA931753 2 pooled tumors (clear cell type), Kidney .f 387 to 645 258 to 1       258/258
(100 %)
2 diff
(99.3 %id)
AA948391 adenocarcinoma, colon .f 388 to 836 449 to 1       449/449
(100 %)
0 diff
(100 %id)
BM145144 leukopheresis .f 391 to 834 460 to 17   AAA   444/444
(100 %)
14 diff
(96.9 %id)
N35120 melanocyte .f 392 to 832 445 to 3       443/445
(99 %)
0 diff
(100 %id)
AI369901 anaplastic oligodendroglioma, brain .f 392 to 836 448 to 4       445/448
(99 %)
0 diff
(100 %id)
FN114312 breast carcinoma .f 393 to 483 1 to 91       91/92
(98 %)
1 diff
(99.0 %id)
AV707627 adrenal gland .f 394 to 834 1 to 441   AAA   441/441
(100 %)
2 diff
(99.6 %id)
BG186638   .f 394 to 834 59 to 506   AAA   448/506
(88 %)
6 diff
(98.9 %id)
AI075836 liver and spleen .f 394 to 834 451 to 11   AAA   441/443
(99 %)
3 diff
(99.4 %id)
H50571 liver and spleen .f 395 to 828 1 to 443       443/443
(100 %)
15 diff
(96.7 %id)
H70236 liver and spleen .f 395 to 652 1 to 265   fully sequenced,   265/265
(100 %)
2 diff
(99.3 %id)
W04143 liver and spleen .f 395 to 830 1 to 433   fully sequenced,   433/433
(100 %)
9 diff
(98.0 %id)
AI056727 brain, glioblastoma (pooled) .f 395 to 836 447 to 6       442/447
(98 %)
0 diff
(100 %id)
N58294 liver and spleen .f 396 to 834 444 to 2       443/527
(84 %)
0 diff
(100 %id)
AI014666   .f 398 to 836 442 to 4       439/442
(99 %)
0 diff
(100 %id)
F37061 pectoral muscle (after mastectomy) .f 398 to 745 1 to 348       348/348
(100 %)
1 diff
(99.8 %id)
DB525363 testis .f 401 to 834 1 to 434     Submitted on the opposite strand 434/434
(100 %)
0 diff
(100 %id)
N24140 melanocyte .f 406 to 834 438 to 1       438/442
(99 %)
17 diff
(96.2 %id)
AI336552 adenocarcinoma, colon .f 407 to 834 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AW073663 2 pooled high-grade transitional celltumors, genitourinary tract .f 410 to 834 453 to 28   AAA   426/426
(100 %)
16 diff
(96.3 %id)
AW014670   .f 410 to 834 442 to 18   AAA   425/425
(100 %)
0 diff
(100 %id)
N54557 liver and spleen .f 411 to 835 430 to 1       430/430
(100 %)
9 diff
(98.0 %id)
AA719417 pineal gland .f 411 to 835 424 to 1       424/424
(100 %)
5 diff
(98.9 %id)
BM771724 stomach .f 411 to 834 1 to 421   AAA   421/421
(100 %)
3 diff
(99.3 %id)
AW182324 pooled .f 416 to 836 424 to 4       421/424
(99 %)
0 diff
(100 %id)
BG202605   .f 419 to 626 97 to 307       211/307
(68 %)
6 diff
(98.1 %id)
DB534816 hippocampus .f 422 to 834 1 to 413     Submitted on the opposite strand 413/413
(100 %)
0 diff
(100 %id)
BU534174 mixed (pool of 40 RNAs) .f 427 to 834 1 to 408       408/408
(100 %)
5 diff
(98.8 %id)
FN152662 breast carcinoma .f 428 to 536 1 to 106       106/106
(100 %)
3 diff
(97.2 %id)
DB508980 testis .f 428 to 834 1 to 408     Submitted on the opposite strand 408/408
(100 %)
1 diff
(99.8 %id)
AI797735 pooled .f 428 to 834 420 to 14   AAA   407/407
(100 %)
2 diff
(99.6 %id)
AA576208 breast, breast tumor .f 431 to 753 327 to 4       324/327
(99 %)
0 diff
(100 %id)
BP388327 pancreatic islet .f 432 to 834 1 to 403   AAA Submitted on the opposite strand 403/403
(100 %)
0 diff
(100 %id)
AI335652 pooled germ cell tumors .f 432 to 836 409 to 5       405/409
(99 %)
0 diff
(100 %id)
AI360960 brain, glioblastoma (pooled) .f 432 to 834 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AW086197 ovary, papillary serous carcinoma .f 434 to 834 416 to 17   AAA   400/400
(100 %)
3 diff
(99.3 %id)
AA701511 liver and spleen .f 436 to 834 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AA885121 pooled .f 436 to 835 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AI026634   .f 437 to 756 320 to 1       320/320
(100 %)
1 diff
(99.7 %id)
AI262338 adenocarcinoma, colon .f 440 to 834 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AI346138 adenocarcinoma, colon .f 440 to 836 397 to 1       397/397
(100 %)
0 diff
(100 %id)
AI446529 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 440 to 834 416 to 22   AAA   395/395
(100 %)
0 diff
(100 %id)
AI498102 anaplastic oligodendroglioma, brain .f 440 to 834 395 to 1       395/395
(100 %)
0 diff
(100 %id)
H40663 brain .f 445 to 758 1 to 315   fully sequenced,   315/315
(100 %)
2 diff
(99.4 %id)
H99753 melanocyte .f 445 to 834 390 to 1       390/390
(100 %)
0 diff
(100 %id)
AA953666 pooled .f 447 to 834 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AA782200 parathyroid gland, parathyroid tumor .f 452 to 808 357 to 1       357/357
(100 %)
0 diff
(100 %id)
AA627360 breast .f 455 to 821 387 to 20       368/387
(95 %)
0 diff
(100 %id)
FN153307 breast carcinoma .f 456 to 518 1 to 63       63/64
(98 %)
1 diff
(98.5 %id)
AA648593 Ewing's sarcoma .f 459 to 837 1 to 379   AAA   379/379
(100 %)
6 diff
(98.5 %id)
CA453603 mixed (pool of 40 RNAs) .f 459 to 835 1 to 377       377/824
(45 %)
2 diff
(99.8 %id)
FN129305 breast carcinoma .f 460 to 526 65 to 1     Submitted on the opposite strand 65/68
(95 %)
2 diff
(97.1 %id)
AA713692 germinal center B cell .f 462 to 834 385 to 13   AAA   373/373
(100 %)
0 diff
(100 %id)
F31733 pectoral muscle (after mastectomy) .f 464 to 688 1 to 225       225/225
(100 %)
0 diff
(100 %id)
AW382331 head_neck .f 467 to 740 1 to 271       271/271
(100 %)
7 diff
(97.5 %id)
AA953525 pooled .f 477 to 834 358 to 1       358/358
(100 %)
0 diff
(100 %id)
AA782844 parathyroid gland, parathyroid tumor .f 483 to 834 352 to 1       352/352
(100 %)
0 diff
(100 %id)
FN067006 breast carcinoma .f 485 to 580 1 to 99       99/99
(100 %)
3 diff
(97.0 %id)
AA328918   .f 493 to 761 1 to 273       273/275
(99 %)
7 diff
(97.5 %id)
AW952439   .f 494 to 834 1 to 342   AAA   342/342
(100 %)
3 diff
(99.2 %id)
BF964201 nervous_normal .f 497 to 717 12 to 232       221/232
(95 %)
6 diff
(97.5 %id)
N29483 melanocyte .f 501 to 834 351 to 1       351/369
(95 %)
19 diff
(94.9 %id)
AI282475 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 502 to 834 352 to 20   AAA   333/333
(100 %)
0 diff
(100 %id)
BE811484 amnion_normal .f 503 to 717 1 to 214       214/214
(100 %)
2 diff
(99.1 %id)
BE811585 amnion_normal .f 503 to 717 215 to 1       215/215
(100 %)
0 diff
(100 %id)
AI300210 placenta .f 505 to 836 335 to 4       332/336
(98 %)
0 diff
(100 %id)
AA512926 breast .f 509 to 721 213 to 1       213/214
(99 %)
0 diff
(100 %id)
T62802 lung .f 518 to 833 1 to 319       319/323
(98 %)
8 diff
(97.6 %id)
EH343770   .f 525 to 593 1 to 69       69/69
(100 %)
0 diff
(100 %id)
AI620903 Prostate .f 525 to 836 315 to 4       312/316
(98 %)
0 diff
(100 %id)
AI243093 liver and spleen .f 527 to 837 318 to 7       312/318
(98 %)
0 diff
(100 %id)
FN134350 breast carcinoma .f 534 to 630 1 to 93       93/95
(97 %)
4 diff
(95.8 %id)
AI000953 breast .f 537 to 833 297 to 1       297/297
(100 %)
2 diff
(99.4 %id)
N70117 liver and spleen .f 549 to 834 291 to 1   fully sequenced,   291/291
(100 %)
0 diff
(100 %id)
AI262339 adenocarcinoma, colon .f 551 to 834 284 to 1       284/284
(100 %)
0 diff
(100 %id)
AA701513 liver and spleen .f 553 to 834 282 to 1       282/282
(100 %)
0 diff
(100 %id)
FN139259 breast carcinoma .f 554 to 646 92 to 1     Submitted on the opposite strand 92/93
(98 %)
1 diff
(99.0 %id)
R38311 placenta .f 562 to 825 285 to 17       269/297
(90 %)
0 diff
(100 %id)
AI277219 placenta .f 566 to 834 269 to 1       269/269
(100 %)
0 diff
(100 %id)
FN064788 breast carcinoma .f 567 to 651 87 to 1     Submitted on the opposite strand 87/88
(98 %)
2 diff
(97.8 %id)
BG291542 bladder, transitional cell papilloma, cell line .f 567 to 834 14 to 281   AAA   268/281
(95 %)
6 diff
(97.9 %id)
BG290304 bladder, transitional cell papilloma, cell line .f 567 to 834 15 to 282   AAA   268/282
(95 %)
6 diff
(97.9 %id)
BE701599 nervous_normal .f 578 to 751 178 to 6       173/178
(97 %)
0 diff
(100 %id)
H50336 brain .f 580 to 823 253 to 1   fully sequenced,   253/253
(100 %)
1 diff
(99.7 %id)
BU536276 mixed (pool of 40 RNAs) .f 580 to 762 1 to 183   AAA   183/183
(100 %)
2 diff
(99.0 %id)
AI955533 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 585 to 836 253 to 2       252/253
(99 %)
0 diff
(100 %id)
BI859904 breast, mammary adenocarcinoma, cell line .f 587 to 834 23 to 271   AAA   249/271
(91 %)
6 diff
(97.8 %id)
AI872684 adenocarcinoma, Pancreas .f 588 to 836 251 to 1       251/251
(100 %)
2 diff
(99.3 %id)
H41269 brain .f 604 to 831 230 to 1       230/230
(100 %)
8 diff
(96.6 %id)
H70237 liver and spleen .f 622 to 825 214 to 1   fully sequenced,   214/214
(100 %)
1 diff
(99.6 %id)
AA834433 adenocarcinoma, colon .f 625 to 826 202 to 1       202/202
(100 %)
0 diff
(100 %id)
AA063133 pineal gland .f 636 to 835 200 to 1     Submitted on the opposite strand 200/200
(100 %)
1 diff
(99.5 %id)
BF340421 brain, glioblastoma with EGFR amplification .f 651 to 834 341 to 527   AAA   458/527
(86 %)
14 diff
(97.4 %id)
R67981 placenta .f 654 to 838 190 to 1   fully sequenced,   190/190
(100 %)
0 diff
(100 %id)
AA709283   .f 657 to 839 189 to 7       183/189
(96 %)
0 diff
(100 %id)
H42989 brain .f 668 to 822 155 to 1   fully sequenced,   155/155
(100 %)
0 diff
(100 %id)
FN130360 breast carcinoma .f 680 to 789 1 to 112       112/112
(100 %)
2 diff
(98.3 %id)
EC452759 Prostate .f 688 to 792 1 to 103       103/103
(100 %)
3 diff
(97.1 %id)
FN089611 breast carcinoma .f 696 to 803 1 to 111       111/111
(100 %)
2 diff
(98.2 %id)
AA181716   .f 698 to 834 153 to 17   AAA   137/137
(100 %)
0 diff
(100 %id)
AI468912 lymph node, lymphoma, follicular mixed small and largecell .f 708 to 834 157 to 31   AAA   127/127
(100 %)
0 diff
(100 %id)
EC455879 Prostate .f 719 to 831 1 to 109       109/109
(100 %)
4 diff
(96.4 %id)
H27877 brain .f 728 to 835 116 to 1   fully sequenced,   116/116
(100 %)
1 diff
(99.2 %id)
FN137792 breast carcinoma .f 744 to 834 1 to 91       91/92
(98 %)
2 diff
(97.9 %id)
FN047259 breast carcinoma .f 753 to 833 1 to 81       81/84
(96 %)
1 diff
(98.9 %id)
FN101376 breast carcinoma .f 757 to 834 1 to 75       75/75
(100 %)
3 diff
(96.0 %id)
FN137418 breast carcinoma .f 761 to 834 74 to 1     Submitted on the opposite strand 74/78
(94 %)
2 diff
(97.5 %id)
T15709   .f 1426 to 1849 429 to 1   tiling clone,   429/431
(99 %)
14 diff
(96.8 %id)
F02248 brain, total brain .f 1596 to 1849 254 to 1       254/254
(100 %)
7 diff
(97.3 %id)
BG527848 lung, mucoepidermoid carcinoma .g 1 to 607 1 to 603 exact tiling clone,   603/842
(71 %)
6 diff
(99.3 %id)
AX775781   .h-u 1 to 2054 2 to 2054 exact tiling clone,   2054/2054
(100 %)
4 diff
(99.9 %id)
DB134978 thymus .h-u 5 to 492 2 to 489 S7P capped   488/488
(100 %)
2 diff
(99.6 %id)
DA382034 thalamus .h-u 16 to 560 2 to 546 exact capped   545/546
(99 %)
2 diff
(99.7 %id)
CD109527 Human Placenta, placenta .h-u 18 to 749 28 to 765 exact     738/765
(96 %)
6 diff
(99.3 %id)
CF994656 Human Placenta, placenta .h-u 18 to 695 28 to 704 exact     677/706
(95 %)
3 diff
(99.6 %id)
H59925 liver and spleen .h-u 33 to 402 1 to 370 L2X E3X A40*     370/370
(100 %)
9 diff
(97.6 %id)
TI_57182302   .h-u 46 to 687 55 to 692 exact tiling clone,   638/692
(92 %)
6 diff
(99.2 %id)
BI771634 pooled lung and spleen .h-u 50 to 687 1 to 635 exact     635/635
(100 %)
4 diff
(99.4 %id)
R45911   .h-u 565 to 705 1 to 141       141/141
(100 %)
0 diff
(100 %id)
AA322990 brain, cerebellum .h-u 938 to 1264 1 to 327   tiling clone,   327/327
(100 %)
0 diff
(100 %id)
BQ881313 dorsal root ganglia .h-u 1615 to 2506 1 to 895   tiling clone,   895/895
(100 %)
7 diff
(99.3 %id)
BM724103 eye, fetal eye .h-u 2035 to 2727 1 to 692   tiling clone, fully sequenced,   692/692
(100 %)
0 diff
(100 %id)
BF447863 carcinoid, lung .h-u 2038 to 2558 538 to 18   AAA   521/521
(100 %)
4 diff
(99.3 %id)
BE937872 testis_normal .h-u 2354 to 2768 1 to 415       415/415
(100 %)
10 diff
(97.6 %id)
BM680290 eye, fetal eye .h-u 2697 to 3280 584 to 1   tiling clone, fully sequenced,   584/584
(100 %)
2 diff
(99.7 %id)
BF058873 fibrotheoma, ovary .i-u 1 to 527 527 to 1 P16L tiling clone,   527/527
(100 %)
2 diff
(99.7 %id)
BF058933 fibrotheoma, ovary .i-u 30 to 527 498 to 1   tiling clone,   498/498
(100 %)
0 diff
(100 %id)
AV702313 adrenal gland Gene SPCS1, variant not shown         Suspected internal deletion, this clone was ignored    
AX775785   Gene SPCS1, variant not shown         This clone was ignored    
AX775787   Gene SPCS1, variant not shown         This clone was ignored    
BC000884 Cervix, carcinoma Gene SPCS1, variant not shown       available from MGC, AAA This clone was ignored    
CV025144 mixed Gene SPCS1, variant not shown         This clone was ignored    
BX474739   Gene SPCS1, variant not shown         This clone was ignored    
N66148 multiple sclerosis lesions Gene SPCS1, variant not shown         Submitted on the opposite strand    
N98671 multiple sclerosis lesions Gene SPCS1, variant not shown         Submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C